According to Omnicell 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.70022. At the end of 2023 the company had a P/S ratio of 2.13.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.13 | 22.59% |
2022 | 1.74 | -75.2% |
2021 | 7.00 | 23.07% |
2020 | 5.69 | 48.27% |
2019 | 3.84 | 22.34% |
2018 | 3.14 | 22.12% |
2017 | 2.57 | 43.73% |
2016 | 1.79 | -21.71% |
2015 | 2.28 | -15.14% |
2014 | 2.69 | 14.58% |
2013 | 2.35 | 47.84% |
2012 | 1.59 | -28.94% |
2011 | 2.23 | 4.15% |
2010 | 2.15 | 22.53% |
2009 | 1.75 | 15.38% |
2008 | 1.52 | -65.31% |
2007 | 4.38 | 27.99% |
2006 | 3.42 | 32.35% |
2005 | 2.58 | 14.9% |
2004 | 2.25 | -40.4% |
2003 | 3.77 | 464.37% |
2002 | 0.6684 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Cerner CERN | N/A | N/A | ๐บ๐ธ USA |
![]() AmerisourceBergen
ABC | 0.1419 | -94.75% | ๐บ๐ธ USA |
![]() Cardinal Health CAH | 0.1068 | -96.05% | ๐บ๐ธ USA |
![]() McKesson MCK | 0.1885 | -93.02% | ๐บ๐ธ USA |
![]() Steris STE | 4.13 | 53.03% | ๐ฎ๐ช Ireland |
![]() Premier PINC | 2.30 | -14.80% | ๐บ๐ธ USA |